Shanghai Haohai Biological Technology Co. Ltd (5HB) - Total Liabilities

Latest as of June 2025: €1.30 Billion EUR ≈ $1.52 Billion USD

Based on the latest financial reports, Shanghai Haohai Biological Technology Co. Ltd (5HB) has total liabilities worth €1.30 Billion EUR (≈ $1.52 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 5HB net asset momentum to track the company's year-over-year net asset growth rate.

Shanghai Haohai Biological Technology Co. Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Shanghai Haohai Biological Technology Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See Shanghai Haohai Biological Technology Co (5HB) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Shanghai Haohai Biological Technology Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Shanghai Haohai Biological Technology Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Shanghai Shibei Hi-Tech Co Ltd B SHG:900902	China	$12.13 Billion
Sekar Laut Tbk JK:SKLT	Indonesia	Rp678.99 Billion
Turker Proje Gayrimenkul Ve Yatirim Gelistirme AS IS:TURGG	Turkey	TL583.33 Million
Tailim Packaging Co Ltd KO:011280	Korea	₩376.99 Billion
TOPTEC Co. Ltd KQ:108230	Korea	₩167.76 Billion
Champions Oncology Inc NASDAQ:CSBR	USA	$24.07 Million
Libertas 7 SA MC:LIB	Spain	€65.34 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Shanghai Haohai Biological Technology Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Shanghai Haohai Biological Technology Co.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.73	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Haohai Biological Technology Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Haohai Biological Technology Co. Ltd (2016–2024)

The table below shows the annual total liabilities of Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	€1.20 Billion ≈ $1.41 Billion	+10.67%
2023-12-31	€1.09 Billion ≈ $1.27 Billion	+9.92%
2022-12-31	€990.02 Million ≈ $1.16 Billion	+11.23%
2021-12-31	€890.07 Million ≈ $1.04 Billion	+57.69%
2020-12-31	€564.46 Million ≈ $659.91 Million	+13.23%
2019-12-31	€498.52 Million ≈ $582.82 Million	-17.04%
2018-12-31	€600.90 Million ≈ $702.52 Million	-15.20%
2017-12-31	€708.59 Million ≈ $828.42 Million	+0.15%
2016-12-31	€707.55 Million ≈ $827.20 Million	--

About Shanghai Haohai Biological Technology Co. Ltd

F:5HB Germany Biotechnology

Market Cap

$74.52 Million

€63.74 Million EUR

Market Cap Rank

#20264 Global

#1849 in Germany

Share Price

€1.78

Change (1 day)

-0.56%

52-Week Range

€1.66 - €3.24

All Time High

€4.70